Loading company…
Scholar Rock develops biopharmaceutical therapies that selectively inhibit growth factors involved in serious diseases.
Founded in 2012 and headquartered in Cambridge, US, Scholar Rock is a biopharmaceutical company. It raised USD 85.00 mn in a Private Placement/Follow on in October 2020 and has executed 10 deals to date. Leonard Zon and Nagesh Mahanthappa co-founded the company, Tony Kingsley is CEO, and the company reported revenue of USD 33.19 mn in 2022 and negative EBITDA of USD 171.29 mn for 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in